Nothing Special   »   [go: up one dir, main page]

DE69006202D1 - Verbesserungen betreffend die Verabreichung pharmazeutischer Mittel. - Google Patents

Verbesserungen betreffend die Verabreichung pharmazeutischer Mittel.

Info

Publication number
DE69006202D1
DE69006202D1 DE90312943T DE69006202T DE69006202D1 DE 69006202 D1 DE69006202 D1 DE 69006202D1 DE 90312943 T DE90312943 T DE 90312943T DE 69006202 T DE69006202 T DE 69006202T DE 69006202 D1 DE69006202 D1 DE 69006202D1
Authority
DE
Germany
Prior art keywords
administration
pharmaceutical agents
flavonoid
bioavailability
pharmaceutical agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90312943T
Other languages
English (en)
Other versions
DE69006202T2 (de
Inventor
David G Bailey
Bo Edgar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Application granted granted Critical
Publication of DE69006202D1 publication Critical patent/DE69006202D1/de
Publication of DE69006202T2 publication Critical patent/DE69006202T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
DE90312943T 1989-11-28 1990-11-28 Verbesserungen betreffend die Verabreichung pharmazeutischer Mittel. Expired - Fee Related DE69006202T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898926715A GB8926715D0 (en) 1989-11-28 1989-11-28 Improvements relating to the administration of pharmaceutical agents

Publications (2)

Publication Number Publication Date
DE69006202D1 true DE69006202D1 (de) 1994-03-03
DE69006202T2 DE69006202T2 (de) 1994-05-05

Family

ID=10666948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90312943T Expired - Fee Related DE69006202T2 (de) 1989-11-28 1990-11-28 Verbesserungen betreffend die Verabreichung pharmazeutischer Mittel.

Country Status (6)

Country Link
US (1) US5229116A (de)
EP (1) EP0431828B1 (de)
AT (1) ATE100323T1 (de)
CA (1) CA2030962C (de)
DE (1) DE69006202T2 (de)
GB (1) GB8926715D0 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6968375B1 (en) * 1997-03-28 2005-11-22 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US7624028B1 (en) 1992-11-17 2009-11-24 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20010011224A1 (en) 1995-06-07 2001-08-02 Stephen James Brown Modular microprocessor-based health monitoring system
US5307263A (en) 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
WO2001037174A1 (en) 1992-11-17 2001-05-25 Health Hero Network, Inc. Method and system for improving adherence with a diet program or other medical regimen
US9215979B2 (en) * 1992-11-17 2015-12-22 Robert Bosch Healthcare Systems, Inc. Multi-user remote health monitoring system
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US5820915A (en) * 1996-06-27 1998-10-13 Bioavailability Systems, L.L.C. Method for the preparation of a first-pass effective citrus-derived substance and product thereof
US6124477A (en) * 1996-06-27 2000-09-26 Bioavailability Systems, Llc Anti-first-pass effect compounds
US6248776B1 (en) 1997-08-26 2001-06-19 Bioavailability Systems, L.L.C. Anti-first-pass effect compounds
US6063809A (en) * 1997-08-26 2000-05-16 Bioavailability Systems, Llc Anti-first-pass effect compounds
WO2001031546A2 (en) * 1999-10-28 2001-05-03 Supersale.Com Method and apparatus for acquiring and providing inventory data
US7169763B2 (en) * 2002-02-22 2007-01-30 Oliver Yoa-Pu Hu Cytochrome P450 3A inhibitors and enhancers
US20060014677A1 (en) * 2004-07-19 2006-01-19 Isotechnika International Inc. Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
US20060111308A1 (en) * 2004-11-16 2006-05-25 Wendye Robbins Methods and compositions for therapeutic treatment
BRPI0608402B8 (pt) * 2005-03-11 2021-05-25 Armaron Bio Pty Ltd compostos de flavonóide e composições compreendendo os mesmos
WO2016134363A1 (en) * 2015-02-20 2016-08-25 Sethi Paul M Compositions comprising benzoyl peroxide or a derivative thereof and at least one antiseptic skin preparation agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE586723A (fr) * 1960-01-19 1960-07-19 Sarec S A Nouveaux composes chimiques et thérapeutiques dérives des isoflavones, et leurs procédés de préparation.
CH444861A (de) * 1963-12-20 1967-10-15 Hoffmann La Roche Antioxydativ wirksames Mittel
DE3419131A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.

Also Published As

Publication number Publication date
EP0431828A1 (de) 1991-06-12
GB8926715D0 (en) 1990-01-17
US5229116A (en) 1993-07-20
DE69006202T2 (de) 1994-05-05
EP0431828B1 (de) 1994-01-19
ATE100323T1 (de) 1994-02-15
CA2030962C (en) 2003-01-28
CA2030962A1 (en) 1991-05-29

Similar Documents

Publication Publication Date Title
DE69006202D1 (de) Verbesserungen betreffend die Verabreichung pharmazeutischer Mittel.
TW355683B (en) Composition containing micronized nebivolol
DE3854148D1 (de) Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten.
ATE247953T1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
EP1283054A4 (de) Medikamente zur behandlung von komplikationen des diabetes und neuropathien, und verwendung davon
ATE232090T1 (de) Orale pharmazeutische zusammensetzungen die pantoprazol mit verzögerter freisetzung und antimikrobielle mittel enthalten
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
CA2282082A1 (fr) Microgranules contenant du cisplatine
HUT70150A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation
FR2697841B1 (fr) Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
IT1217445B (it) Composizione farmaceutiche orosolubili contenti acetilcisteina
HUP0105481A2 (hu) Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
KR910005858A (ko) 지방산 요법
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
IL104005A0 (en) Piperidylmethyl-substituted chroman derivatives,their preparation and pharmaceutical compositions containing them
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
IT1204400B (it) Composizioni farmaceutiche contenente una calcitonina
ATE173624T1 (de) Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
EP0271151A3 (de) Azumolen-Dosisformen
GB9202993D0 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
KR930019221A (ko) 성인병 예방 및 치료용 순환계용계약 조성물
HUT51641A (en) Process for producing pseudoprimycin and its components, as well as pharmaceutical compositions comprising such active ingredient
IL96161A0 (en) Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee